Home / Guides / GLP-1 & Metabolic Peptides

GLP-1 & Metabolic Peptides

The metabolic peptides behind the weight-management wave — GLP-1 and next-generation agonists — grouped with a neutral look at the evidence and how they differ. Every claim is sourced on each peptide's guide.

By The Health Stacks Research Team

Semaglutide

533 studies Approved

GLP-1 receptor agonist studied for glucose regulation and weight outcomes.

Read the full Semaglutide guide →

Tirzepatide

310 studies Research

Dual GIP/GLP-1 agonist studied for metabolic and weight outcomes.

Read the full Tirzepatide guide →

Retatrutide

91 studies Research

Emerging triple agonist studied for weight and metabolic markers.

Read the full Retatrutide guide →

MOTS-c

43 studies Research

Mitochondrial-derived peptide studied for metabolic regulation.

Read the full MOTS-c guide →

Compare Them Head-to-Head

Semaglutide vs Tirzepatide →Semaglutide vs Retatrutide →Tirzepatide vs Retatrutide →

Educational content only, not medical advice. Peptides discussed are generally research compounds, not FDA-approved for human use unless stated. Every claim is sourced on the individual peptide guides. Consult a healthcare professional before use.